María Marcos Jubilar-rekin lankidetzan egindako argitalpenak (10)

2024

  1. Factor XI inhibitors: A new era in antithrombotic therapy

    Medicina Clinica

  2. Immunothrombosis: A key mechanism in the COVID-19 pandemic

    Medicina Clinica

2023

  1. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives

    Journal of Clinical Medicine, Vol. 12, Núm. 4

2022

  1. Impact of the mutation profile on thrombotic risk in cancer patients

    Revista Clinica Espanola, Vol. 222, Núm. 2, pp. 93-99

2021

  1. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  3. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    TH Open

  4. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications

    Transfusion Medicine, Vol. 29, Núm. 4, pp. 268-274

2014

  1. Seguridad y eficacia de un concentrado de complejo protrombínico en pacientes con coagulopatía y hemorragia

    Anales del sistema sanitario de Navarra, Vol. 37, Núm. 3, pp. 363-369